Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
This study aimed to compare conventional medication management of type 2 diabetes (T2D) to medication management in conjunction with a lifestyle intervention using continuous glucose monitoring to minimize glucose excursions. Thirty adults (63% female; mean age, 53.3 years) who were diagnosed with T2D for less than 11 years (mean, 5.6 years), had glycated A1c (HbA1c) ≥ 7.0% (51 mmol/mol) (mean 8.8%, [73 mmol/mol]), and were not using insulin, were randomly assigned in a 1:2 ratio to routine care (RC) or 4 group sessions of glycemic excursion minimization plus real-time CGM (GEMCGM). Assessments at baseline and 5 months included a physical exam, metabolic and lipid panels, a review of diabetes medications, and psychological questionnaires. For the week following assessments, participants wore a blinded activity monitor and completed 3 days of 24-hour dietary recall. A subgroup also wore a blinded CGM. GEMCGM participants significantly improved HbA1c (from 8.9% to 7.6% [74-60 mmol/mol] compared with 8.8% to 8.7% [73-72 mmol/mol] for RC (P = .03). Additionally, GEMCGM reduced the need for diabetes medication (P = .01), reduced carbohydrate consumption (P = .009), and improved diabetes knowledge (P = .001), quality of life (P = .01) and diabetes distress (P = .02), and trended to more empowerment (P = .05) without increasing dietary fat, lipids, or hypoglycemia. Confirming our prior research, GEMCGM appears to be a safe, effective lifestyle intervention option for adults with suboptimally controlled T2D who do not take insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cox and colleagues reported lower carbohydrate consumption and higher empowerment and knowledge scores with lower diabetes distress in noninsulin users who had received the CGM plus education intervention. 50”
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, rtCGM has been associated with improvements in the medication effect score (MES) and the Diabetes Distress Scale (DDS) 50 while isCGM has been positively linked with the Summary of Diabetes Self‐Care Activities Questionnaire (SDSCA‐K). 28 , 30”
The cited source says what the claim attributes to it.
In the citing paper
“Imputing the maximum SD in place of the mean SD in the trial by Cox and colleagues 50 did not affect the significance of the results for TIR, TBR, and TAR outcomes.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 1×
“The American Diabetes Association recommends 150 minutes per week of moderate physical activity plus 7% weight loss through caloric restriction [1].”
BackgroundAssessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Subar, A. F., Kirkpatrick, S. I., Mittl, B., Zimmerman, T. P., Thompson, F. E., Bingley, C., Willis, G., Islam, N. G., Baranowski, T., McNutt, S., et al. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.04.016 · Cited by 934
International Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608
The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy.
Anderson, R. M., Funnell, M. M., Fitzgerald, J. T., & Marrero, D. G. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.739 · Cited by 568
The International Hypoglycaemia Study Group (2017) · Diabetologia · doi:10.1007/s00125-016-4146-6 · Cited by 360
Introduction: Standards of Medical Care in Diabetes—2020
(2020) · Diabetes Care · doi:10.2337/dc20-sint · Cited by 331
Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update
Ceriello, A., Davidson, J., Hanefeld, M., Leiter, L. A., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. O. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.006 · Cited by 166
Research works printed but not linked: 2
- Cox, 2018, Continuous glucose monitoring functions as a negative feedback loop for individuals with type 2 diabetes, Ann Diabetes Metab Disorders Control., 1, 121
- World Health Organization., 2004, The world health organization quality of life (WHOQOL)-BREF.
Cited by
Seidu, S., Kunutsor, S. K., Ajjan, R. A., & Choudhary, P. (2024) · Diabetes Care · doi:10.2337/dc23-1520 · Cited by 124
Aronson, R., Brown, R. E., Chu, L., Bajaj, H. S., Khandwala, H., Abitbol, A., Malakieh, N., & Goldenberg, R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14949 · Cited by 118
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00973-1 · Cited by 117
“…in people with T2DM not on insulin therapy, include: increased hypo-glycaemic confidence, reduced diabetes mellitus distress and better overall wellbeing 79,80 , as well as improved psychological function, diabetes mellitus empowerment and greater diabetes mellitus treatment satisfaction 62,63 .”
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Jackson, M. A., Ahmann, A., & Shah, V. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0007 · Cited by 106
“created a model using education and lifestyle interventions to minimize glucose excursions and employed rtCGM (Dexcom Platinum G4) to educate patients on the effects of eating and activity choices previously demonstrated to reduce glycemic variability.(22) They found not only an improvement in HbA1c but also a remarka…”
MethodFerreira, R. O. M., Trevisan, T., Pasqualotto, E., Chavez, M. P., Marques, B. F., Lamounier, R. N., & van de Sande-Lee, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0390 · Cited by 92
Metadata
- Authors
- Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L.
- Affiliations
- University of Virginia (US)
- Corresponding author
- Cox, Daniel J
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2020-08-18
- Volume
- 4
- Issue
- 11
- Pages
- bvaa118-bvaa118
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC7566397
- OpenAlex
- W3073688883
- Cited by
- 82
- References
- 15
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 18 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 1
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Dexcom, Inc (IIS-2017-047)
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK108957)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, continuous glucose monitoring, lifestyle intervention, glycemic control, HbA1c, diabetes medication reduction, carbohydrate intake, diabetes knowledge, diabetes distress, quality of life, patient empowerment, non-insulin-treated diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1210/jendso/bvaa118
- The paper
- Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L. (2020). Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvaa118
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.